Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium.


Journal

Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 03 07 2023
revised: 07 08 2023
accepted: 06 10 2023
medline: 4 12 2023
pubmed: 31 10 2023
entrez: 31 10 2023
Statut: ppublish

Résumé

The Arthur and Sandra Irving Cancer Immunology Symposium has been created as a platform for established cancer immunologists to mentor trainees and young investigators as they launch their research career in the field. By sharing their different paths to success, the senior faculty mentors provide an invaluable resource to support the development of the next generation of leaders in the cancer immunology community. This Commentary describes some of the key topics that were discussed during the 2022 symposium: scientific and career trajectory, leadership, mentoring, collaborations, and publishing. For each of these topics, established investigators discussed the elements that facilitate success in these areas as well as mistakes that can hinder progress. Herein, we outline the critical points raised in these discussions for establishing a successful independent research career. These points are highly relevant for the broader scientific community.

Identifiants

pubmed: 37906619
pii: 729890
doi: 10.1158/2326-6066.CIR-23-0522
pmc: PMC10696930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1571-1577

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Auteurs

Christopher Alvarez-Breckenridge (C)

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Kristin G Anderson (KG)

Department of Microbiology, Immunology and Cancer Biology, Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia.
Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, Virginia.

Ana Luisa Correia (AL)

Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.

Shadmehr Demehri (S)

Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Huy Q Dinh (HQ)

McArdle Laboratory for Cancer Research/Department of Oncology, Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Karen Olivia Dixon (KO)

Department of Neurology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.

Gavin P Dunn (GP)

Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Laura Evgin (L)

Michael Smith Genome Sciences Department, BC Cancer Research Institute, Vancouver, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

Jeremy Goc (J)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, New York.
Joan and Sanford I. Weill Department of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, Cornell University, New York, New York.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, New York.

Zinaida Good (Z)

Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California.

Nir Hacohen (N)

Center for Cancer Immunology, Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Patrick Han (P)

Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Pavel Hanč (P)

Department of Immunology, Harvard Medical School, Boston, Massachusetts.

John Hickey (J)

Department of Pathology, Stanford University School of Medicine, Stanford, California.

Kelly Kersten (K)

Department of Pathology, University of California San Francisco, San Francisco, California.

Beiyun C Liu (BC)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee.

Aitziber Buque (A)

Department of Radiation Oncology, Weill Cornell Medical College, New York, New York.

Yuxuan 'Phoenix' Miao (Y')

Ben May Department of Cancer Research, The University of Chicago, Chicago, Illinois.

J Justin Milner (JJ)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Yuri Pritykin (Y)

Lewis-Sigler Institute for Integrative Genomics and Department of Computer Science, Princeton University, New Jersey.

Ferdinando Pucci (F)

Department of Otolaryngology and Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.

Nicole E Scharping (NE)

Division of Biological Sciences, Section of Molecular Biology, University of California, San Diego, La Jolla, California.

Lisa Sudmeier (L)

Department of Radiation Oncology, Winship Cancer Institute and Emory University School of Medicine, Atlanta, Georgia.

Yufei Wang (Y)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

Andreas Wieland (A)

Department of Otolaryngology and Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio.

Michelle M Williams (MM)

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH